User profiles for L. Antonioli

Luca Antonioli

Dept Clinical and Experimental Medicine University of Pisa
Verified email at medmcs.unipi.it
Cited by 9404

CD39 and CD73 in immunity and inflammation

L Antonioli, P Pacher, ES Vizi, G Haskó - Trends in molecular medicine, 2013 - cell.com
The enzymatic activities of CD39 and CD73 play strategic roles in calibrating the duration,
magnitude, and chemical nature of purinergic signals delivered to immune cells through the …

Immunity, inflammation and cancer: a leading role for adenosine

L Antonioli, C Blandizzi, P Pacher, G Haskó - Nature Reviews Cancer, 2013 - nature.com
Cancer is a complex disease that is dictated by both cancer cell-intrinsic and cell-extrinsic
processes. Adenosine is an ancient extracellular signalling molecule that can regulate almost …

Anti-CD73 in cancer immunotherapy: awakening new opportunities

L Antonioli, GG Yegutkin, P Pacher, C Blandizzi… - Trends in cancer, 2016 - cell.com
Over recent years, significant advances in cancer immunotherapy have been made due to a
better understanding of the principles underlying tumor biology and immunology. In this …

A long-term prognostic value of coronary CT angiography in suspected coronary artery disease

…, S Mushtaq, AL Bartorelli, E Bertella, L Antonioli… - JACC: Cardiovascular …, 2012 - jacc.org
Objectives : The aim of this study was to assess the long-term prognostic role of multidetector
computed tomography coronary angiography (CTA) in patients with suspected coronary …

Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?

C Pellegrini, L Antonioli, R Colucci, C Blandizzi… - Acta …, 2018 - Springer
Neurological diseases, such as Parkinson’s disease, Alzheimer’s disease, amyotrophic
lateral sclerosis (ALS) and multiple sclerosis, are often associated with functional …

[HTML][HTML] Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation

C Pellegrini, L Antonioli, G Lopez-Castejon… - Frontiers in …, 2017 - frontiersin.org
Several lines of evidence point out the relevance of nucleotide-binding oligomerization domain
leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome as a …

Adenosine and inflammation: what's new on the horizon?

L Antonioli, B Csóka, M Fornai, R Colucci, E Kokai… - Drug Discovery …, 2014 - Elsevier
… Other studies have confirmed the beneficial effects of A 1 blockade on allergen-induced
bronchoconstriction by showing the efficacy of L-97-1 (3-[2-(4-aminophenyl)-ethyl]-8-benzyl-7-{2-…

Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations

L Antonioli, C Blandizzi, B Csóka, P Pacher… - Nature reviews …, 2015 - nature.com
… 1 adenosine receptor agonist, N 6 -L-phenyl-isopropyl-adenosine (L-PIA). This finding was
… which also demonstrated that the inhibitory action of L-PIA on insulin release was attributable …

The intestinal barrier in disorders of the central nervous system

…, M Fornai, V D'Antongiovanni, L Antonioli… - The lancet …, 2023 - thelancet.com
The intestinal barrier, which primarily consists of a mucus layer, an epithelial barrier, and a
gut vascular barrier, has a crucial role in health and disease by facilitating nutrient absorption …

Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders

L Antonioli, R Colucci, C La Motta, M Tuccori… - Current drug …, 2012 - ingentaconnect.com
The adenosine pathway is a powerful evolutionarily selected mechanism aimed at a fine
modulation of inflammatory responses and protection of tissues from injuries. Adenosine exerts …